#Fight4Hematology #HemeSky #MedSky
#Fight4Hematology #HemeSky #MedSky
This is not normal and not “making American great” and I vehemently oppose any thoughts to the contrary. #StandWithUkraine
This is not normal and not “making American great” and I vehemently oppose any thoughts to the contrary. #StandWithUkraine
If I were Canadian PM I would immediately:
1. Create a new $15B science fund
2. Offer any credentialed US scientist funding for lab startup and replacement of NIH grants if they move to Canada
3. Immediate permanent residency
4. Citizenship after 2 years
Overnight a science superpower
If I were Canadian PM I would immediately:
1. Create a new $15B science fund
2. Offer any credentialed US scientist funding for lab startup and replacement of NIH grants if they move to Canada
3. Immediate permanent residency
4. Citizenship after 2 years
Overnight a science superpower
✨I’ve officially accepted a position as an attending physician at LCI!✨
I will be doing what I love and focusing on lymphoma and classical hematology patients! My family and I are so excited.
✨I’ve officially accepted a position as an attending physician at LCI!✨
I will be doing what I love and focusing on lymphoma and classical hematology patients! My family and I are so excited.
It’s a shame to have to crowdfund for healthcare these days, but this is America.
#MedSky #NephroSky
gofund.me/16c8c72b
It’s a shame to have to crowdfund for healthcare these days, but this is America.
#MedSky #NephroSky
gofund.me/16c8c72b
My baby:
My baby:
Am I now residing in some sort of unhinged alternate dimension?
And every day the evidence tells me that yes, I am now residing in some sort of mad universe
Am I now residing in some sort of unhinged alternate dimension?
And every day the evidence tells me that yes, I am now residing in some sort of mad universe
An important footnote for all the CAR-T vs bsAb efficacy debates: when stratified by MRD status, CAR-T and bsAbs do identically.
Getting to MRD neg is what matters!
onlinelibrary.wiley.com/doi/10.1002/...
An important footnote for all the CAR-T vs bsAb efficacy debates: when stratified by MRD status, CAR-T and bsAbs do identically.
Getting to MRD neg is what matters!
onlinelibrary.wiley.com/doi/10.1002/...